Final results of a phase 3 study of trebananib plus weekly...

Final results of a phase 3 study of trebananib plus weekly paclitaxel in recurrent ovarian cancer (TRINOVA-1): Long-term survival, impact of ascites, and progression-free survival-2

Monk, Bradley J., Poveda, Andrés, Vergote, Ignace, Raspagliesi, Francesco, Fujiwara, Keiichi, Bae, Duk-Soo, Oaknin, Ana, Ray-Coquard, Isabelle, Provencher, Diane M., Karlan, Beth Y., Lhommé, Catherine
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
143
Language:
english
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2016.07.112
Date:
October, 2016
File:
PDF, 1.09 MB
english, 2016
Conversion to is in progress
Conversion to is failed